Drugs

U.S. officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.

First aryl hydrocarbon receptor agonist results in downregulation of proinflammatory cytokines, skin-barrier normalization and antioxidant activity.